Showing 911-920 of 1008 results for "".
- The Newest Xeomin Brand Partner is Joe Jonashttps://modernaesthetics.com/news/the-newest-xeomin-brand-partner-is-joe-jonas/2473280/Joe Jonas is the latest Xeomin (incobotulinumtoxinA) brand partner, Merz Aesthetics announced. The U.S. partnership with Jonas kicks off a new ‘Beauty on Your Terms’ campaign for Xeomin and represents the first time the singer, songwriter and actor has pa
- AIVA Launches IV Hydration Therapy Business Academy Eventshttps://modernaesthetics.com/news/aiva-launches-iv-hydration-therapy-business-academy-events/2473270/The American IV Association (AIVA) is launching two IV Hydration Therapy Business Academy events to assist anyone getting into the IV hydration therapy business, adding IV hydration therapy to an existing practice, or those looking to grow their existing practice. Each one-day even
- Bryant Wong Named Sciton’s first CFOhttps://modernaesthetics.com/news/bryant-wong-named-scitons-first-cfo/2473259/Bryant Wong is Sciton’s first Chief Financial Officer, effective immediately. The announcement was made at Sciton's 25th Anniversary celebration. The year 2022 exemplifies Sciton's ongoing commitment to quality and improvement, with recognition such as 2022 Company of the
- New Aesthetic Society Data: Facelifts, Breast Procedures, and Body Procedures Surged in 2021https://modernaesthetics.com/news/new-aesthetic-society-data-facelifts-breast-procedures-and-body-procedures-surged-in-2021/2473217/Plastic surgery is booming, according to the Aesthetic Society’s annual
- Aquavit's Neurotoxin Submitted to FDAhttps://modernaesthetics.com/news/aquavits-neurotoxin-submitted-to-fda/2473213/Aquavit Pharmaceuticals, Inc. has submitted its IND for a new botulinum toxin (DTX-021) to the FDA for approval. The company also unveiled its development programs at the Annual meeting of the American Academy of Dermatology in Boston. DTX-021, a botulinum toxin type A drug intende
- Laser Surgery Lawsuits May be Less Likely with Physician Operatorshttps://modernaesthetics.com/news/laser-surgery-lawsuits-may-be-less-likely-with-physician-operators/2473208/The majority of liability claims due to a cutaneous laser surgery device between 2012 and 2020 involved a non-physician operator, according to a new study in the March 2022 issue of Dermatologic Surgery. Researchers analyzed cases of liability claims due to a cutaneou
- AAFPRS 2021 Survey: Demand for Facial Plastic Surgery Continues to Skyrockethttps://modernaesthetics.com/news/aafprs-2021-survey-demand-for-facial-plastic-surgery-continues-to-skyrocket/2473196/Despite lingering pandemic concerns, 2021 saw catapulting demand for facial plastic surgery and aesthetic procedures as in-person events and face-to-face socialization resumed, according to the annual statistics from the
- Done Deal: RoundTable Healthcare Partners Completes Sale of Revision Skincare and Goodier Cosmetics to Gryphon Investorshttps://modernaesthetics.com/news/done-deal-roundtable-healthcare-partners-completes-sale-of-revision-skincare-and-goodier-cosmetics-to-gryphon-investors/2473172/RoundTable Healthcare Partners completed the previously announced sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors. Terms of the transaction were not disclosed. Revision Skincare’s portfolio includes Nectifirm, Intellishade, D·E·J
- FDA Tightens Breast Implant Safety Requirements, Updates Study Resultshttps://modernaesthetics.com/news/fda-tightens-breast-implant-safety-requirements-updates-study-results/2473159/FDA is calling for stronger warnings on breast implants including a boxed warning, which lists such potential risks as infection, rupture, capsular contraction, breast implant illness, and breast implant-associated anaplastic large cell Lymphoma (BIA-ALCL).
- Bausch Health Pursues IPO of Solta Medicalhttps://modernaesthetics.com/news/bausch-health-pursues-ipo-of-solta-medical/2473130/Bausch Health Companies Inc. is planning to pursue an initial public offering (IPO) of its Solta Medical business. Solta’s portfolio includes the Thermage RF systems, Fraxel laser, Clear + Brilliant laser and VASER ultrasonic systems. The timing of the anticipated IPO, w